SCHEMBL19000554

SCHEMBL19000554

CC(C)c1ccc(C(Oc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)C(=O)NCCO[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 2/20 0.39
▸ HIF1A Q16665 2/20 0.35
▸ DGAT1 O75907 1/20 0.35
▸ GCGR P47871 3/20 0.33
▸ ADCY6 O43306 1/20 0.33
▸ ADCY3 O60266 1/20 0.33
▸ ADCY9 O60503 1/20 0.33
▸ ADCY5 O95622 1/20 0.33
▸ ADCY8 P40145 1/20 0.33
▸ ADCY7 P51828 1/20 0.33
▸ ADCY2 Q08462 1/20 0.33
▸ ADCY1 Q08828 1/20 0.33
▸ ADCY4 Q8NFM4 1/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ CA9 Q16790 3/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17129678 0.83 AAK1 (0.39) AAK1HIF1ADGAT1GCGRADCY6
SCHEMBL17129277 0.79 CA1 (0.41) AAK1HIF1ADGAT1CA1CA2
SCHEMBL19000518 0.76 CA1 (0.42) AAK1HIF1ADGAT1CA1CA2
SCHEMBL19000552 0.76 CA1 (0.44) AAK1HIF1ACA1CA2CA9
SCHEMBL20976388 0.73 NAAA (0.39) SMN1; SMN2RAB9A
SCHEMBL22234149 0.71 LPL (0.41) AAK1DGAT1CA1CA2CA9
SCHEMBL17129349 0.71 AAK1 (0.53) AAK1HIF1ADGAT1CA1CA2
SCHEMBL21217718 0.70 AAK1 (0.49) AAK1HIF1ADGAT1CA1CA2
SCHEMBL15905496 0.70 CA1 (0.42) AAK1DGAT1CA1CA2CA9
SCHEMBL20540359 0.70 CA1 (0.43) AAK1HIF1ADGAT1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10280170-B2 Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors JANSSEN PHARMACEUTICA NV (BE) 2019-05-07 — — US disclosed
US-20170174690-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280170-B2 Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors ROS1, NOX1, NOX5 AAK1 1311/4885HIF1A 1192/4885DGAT1 2213/4885
US-20170174690-A1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS ROS1, NOX1, NOX5 AAK1 1311/4885HIF1A 1192/4885DGAT1 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback